ES461175A1 - Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation - Google Patents

Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation

Info

Publication number
ES461175A1
ES461175A1 ES461175A ES461175A ES461175A1 ES 461175 A1 ES461175 A1 ES 461175A1 ES 461175 A ES461175 A ES 461175A ES 461175 A ES461175 A ES 461175A ES 461175 A1 ES461175 A1 ES 461175A1
Authority
ES
Spain
Prior art keywords
benzamides
oxy
derivatives
substituted
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES461175A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Original Assignee
Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7623835A external-priority patent/FR2360305A1/en
Application filed by Societe dEtudes Scientifiques et Industrielles de lIle de France SA filed Critical Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Publication of ES461175A1 publication Critical patent/ES461175A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/10—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Novel substituted 2,3-alkylene bis (oxy) benzamides and derivatives thereof are disclosed. Also disclosed is a method for producing said compounds. The compounds have anxiolytic, psychostimulant, disinhibiting and thymoanaleptic properties useful therapeutically in the psychofunctional field, particularly in gastro-enterology, cardiology, urology, rheumatology and gynaecology.
ES461175A 1976-08-04 1977-07-29 Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation Expired ES461175A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7623835A FR2360305A1 (en) 1976-08-04 1976-08-04 NEW 2,3-ALKYLENE BIS (OXY) BENZAMIDE SUBSTITUTES, THEIR DERIVATIVES AND THEIR PREPARATION METHODS

Publications (1)

Publication Number Publication Date
ES461175A1 true ES461175A1 (en) 1978-12-01

Family

ID=9176558

Family Applications (1)

Application Number Title Priority Date Filing Date
ES461175A Expired ES461175A1 (en) 1976-08-04 1977-07-29 Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation

Country Status (37)

Country Link
JP (1) JPS57167914A (en)
AR (1) AR219709A1 (en)
AT (1) AT358034B (en)
AU (1) AU516033B2 (en)
BE (1) BE857350A (en)
BG (1) BG36496A3 (en)
CA (1) CA1114371A (en)
CH (1) CH629198A5 (en)
CS (1) CS216246B2 (en)
DD (1) DD133237A5 (en)
DE (1) DE2760414C2 (en)
DK (1) DK152366C (en)
EG (1) EG12716A (en)
ES (1) ES461175A1 (en)
FI (1) FI63938C (en)
GR (1) GR61351B (en)
HK (2) HK40382A (en)
HU (1) HU179064B (en)
IE (2) IE45646B1 (en)
IL (2) IL52644A0 (en)
IN (1) IN145473B (en)
LU (1) LU77897A1 (en)
MC (1) MC1154A1 (en)
MW (1) MW2077A1 (en)
NL (1) NL172063C (en)
NO (1) NO152133C (en)
NZ (1) NZ184816A (en)
OA (1) OA05728A (en)
PH (3) PH22114A (en)
PL (1) PL111071B1 (en)
PT (1) PT66865B (en)
RO (1) RO72963A (en)
SE (2) SE440776B (en)
SU (1) SU716523A3 (en)
YU (1) YU40005B (en)
ZA (1) ZA774701B (en)
ZM (1) ZM6077A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027098D0 (en) * 1990-12-13 1991-02-06 Beecham Group Plc Pharmaceuticals
US10083697B2 (en) 2015-05-27 2018-09-25 Google Llc Local persisting of data for selectively offline capable voice action in a voice-enabled electronic device
JP6452575B2 (en) * 2015-08-19 2019-01-16 株式会社トクヤマ Manufacturing method of mirtazapine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1473829A (en) * 1964-06-09 1967-03-24 Ile De France Nu- (tertiary-aminoalkyl) -methylene dioxybenzamides and their preparation

Also Published As

Publication number Publication date
AT358034B (en) 1980-08-11
NZ184816A (en) 1980-11-14
PL111071B1 (en) 1980-08-30
JPS57167914A (en) 1982-10-16
IN145473B (en) 1978-10-21
SU716523A3 (en) 1980-02-15
DD133237A5 (en) 1978-12-20
PH18629A (en) 1985-08-23
NL172063B (en) 1983-02-01
ZM6077A1 (en) 1979-05-21
FI772362A7 (en) 1978-02-05
ATA569677A (en) 1980-01-15
DK346977A (en) 1978-02-05
FI63938C (en) 1983-09-12
DK152366C (en) 1988-07-25
FI63938B (en) 1983-05-31
HU179064B (en) 1982-08-28
IE802409L (en) 1978-02-04
NL7708616A (en) 1978-02-07
IE45646B1 (en) 1982-10-20
DK152366B (en) 1988-02-22
SE437027B (en) 1985-02-04
IE45647B1 (en) 1982-10-20
YU188277A (en) 1983-01-21
CS216246B2 (en) 1982-10-29
AR219709A1 (en) 1980-09-15
SE8206546L (en) 1982-11-17
AU516033B2 (en) 1981-05-14
NO152133B (en) 1985-04-29
PH17710A (en) 1984-11-19
DE2760414C2 (en) 1990-05-17
SE453390B (en) 1988-02-01
JPS6259090B2 (en) 1987-12-09
AU2750777A (en) 1979-02-08
PT66865A (en) 1977-08-01
CA1114371A (en) 1981-12-15
PL200066A1 (en) 1978-09-11
SE7708849L (en) 1978-02-05
LU77897A1 (en) 1978-02-09
HK40482A (en) 1982-09-24
IL66138A0 (en) 1982-09-30
BG36496A3 (en) 1984-11-15
BE857350A (en) 1978-02-01
GR61351B (en) 1978-10-26
HK40382A (en) 1982-09-24
SE440776B (en) 1985-08-19
NL172063C (en) 1983-07-01
CH629198A5 (en) 1982-04-15
RO72963A (en) 1981-11-24
ZA774701B (en) 1979-01-31
OA05728A (en) 1981-05-31
SE8206546D0 (en) 1982-11-17
PH22114A (en) 1988-06-01
MW2077A1 (en) 1978-12-13
PT66865B (en) 1978-12-29
EG12716A (en) 1979-09-30
NO152133C (en) 1985-08-07
IE45646L (en) 1978-02-04
IL52644A0 (en) 1977-10-31
NO772739L (en) 1978-02-07
MC1154A1 (en) 1978-04-17
YU40005B (en) 1985-06-30

Similar Documents

Publication Publication Date Title
BG28061A3 (en) Method of obtaining of hexahydrodibenzopyranones
BG31946A4 (en) METHOD FOR OBTAINING 4-ACYLAMINO-PHENYL-ETHANOLAMINE
BG32850A3 (en) Method for obtaining of 6 a, 10 a- cis- hexahydrodibenzopyranols
BG34908A3 (en) METHOD FOR OBTAINING D- 6- N-PROPYLERGOLINES
AU2926977A (en) Production of Fluorine
BG28068A3 (en) METHOD FOR OBTAINING -3- CHLORCEPHALOSPORINS
JPS5334709A (en) Method of producing ether
BG35042A3 (en) Method for preparing benzodiazepinic compounds
AU515722B2 (en) A method of producing cross laminates
ES461175A1 (en) Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation
AU518020B2 (en) Production of hydrocarbon soluble organo-magnesium complexes
AU505874B2 (en) Synthesis of faujasite
BG28064A3 (en) Method of obtaining of 2,6-methane-2h-1-benzoxozines
BG34452A3 (en) Method for obtaining cephalosporines
BG33295A3 (en) METHOD OF OBTAINING VINDEZINE
BG37840A3 (en) METHOD FOR OBTAINING ORTHOCONDENSED PYRROLE DERIVATIVES
SE7714465L (en) ANTITUMOR ASSOCIATIONS AND PROCEDURES FOR THE MANUFACTURE THEREOF
SU665807A3 (en) Method of producing beta-methyldigoxin
BG30017A3 (en) Method for obtaining of bensoilcarbrmid
BG30925A3 (en) Method for thiocharbamate derivatives obtaining
BG29869A3 (en) Method for obtaining of octapeptideamidosulphate ester of holestokinin- pancreocimine
AU518756B2 (en) Production of monochlord-diamino-s-triazines
AU515013B2 (en) Production of haloacylamides
SU583172A1 (en) Method of producing stainless steel
AU2285477A (en) Process forthe preparation of 4-cyano-thiazole

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19981103